Axovant Plans Nelotanserin PhIII But Trial Endpoint Has Eyebrows Raised

 
• By Lucie Ellis-Taitt
  
EraseDementia_1200x675
Axovant will take dementia drug into Phase III later this year • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D